TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts.

Détails

Ressource 1Télécharger: 5_17942754_Postprint.pdf (1528.24 [Ko])
Etat: Public
Version: Author's accepted manuscript
ID Serval
serval:BIB_98D032586046
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts.
Périodique
Blood
Auteur⸱e⸱s
Bossen C., Cachero T.G., Tardivel A., Ingold K., Willen L., Dobles M., Scott M.L., Maquelin A., Belnoue E., Siegrist C.A., Chevrier S., Acha-Orbea H., Leung H., Mackay F., Tschopp J., Schneider P.
ISSN
0006-4971
Statut éditorial
Publié
Date de publication
2008
Peer-reviewed
Oui
Volume
111
Numéro
3
Pages
1004-1012
Langue
anglais
Résumé
The cytokine BAFF binds to the receptors TACI, BCMA, and BAFF-R on B cells, whereas APRIL binds to TACI and BCMA only. The signaling properties of soluble trimeric BAFF (BAFF 3-mer) were compared with those of higher-order BAFF oligomers. All forms of BAFF bound BAFF-R and TACI, and elicited BAFF-R-dependent signals in primary B cells. In contrast, signaling through TACI in mature B cells or plasmablasts was only achieved by higher-order BAFF and APRIL oligomers, all of which were also po-tent activators of a multimerization-dependent reporter signaling pathway. These results indicate that, although BAFF-R and TACI can provide B cells with similar signals, only BAFF-R, but not TACI, can respond to soluble BAFF 3-mer, which is the main form of BAFF found in circulation. BAFF 60-mer, an efficient TACI agonist, was also detected in plasma of BAFF transgenic and nontransgenic mice and was more than 100-fold more active than BAFF 3-mer for the activation of multimerization-dependent signals. TACI supported survival of activated B cells and plasmablasts in vitro, providing a rational basis to explain the immunoglobulin deficiency reported in TACI-deficient persons.
Mots-clé
Amino Acid Sequence, Animals, Antibodies, Antibody Formation, B-Cell Activating Factor, B-Cell Activation Factor Receptor, B-Lymphocytes, Cell Line, Cell Proliferation, Histocompatibility Antigens Class II, Humans, Immunoglobulins, Ligands, Lymphocyte Activation, Mice, Mice, Knockout, Mice, Transgenic, Molecular Sequence Data, Sequence Alignment, Signal Transduction, Spleen, Transmembrane Activator and CAML Interactor Protein, Tumor Necrosis Factor Ligand Superfamily Member 13, Up-Regulation
Pubmed
Web of science
Open Access
Oui
Création de la notice
29/01/2009 22:14
Dernière modification de la notice
20/08/2019 15:00
Données d'usage